Walmart Announces 3-for-1 Stock Split

Walmart Inc. (NYSE: WMT) announced that it will conduct a split of its outstanding shares of common stock at a ratio of 3:1. The stock split is part of Walmart’s ongoing review of optimal trading and spread levels and its desire for its associates to feel that purchasing shares is easily within reach. More than 400,000 associates participate in Walmart’s Associate Stock Purchase Plan today, which allows eligible associates to buy stock conveniently through payroll deductions and provides a 15% company match on the first $1,800 each year.

“Sam Walton believed it was important to keep our share price in a range where purchasing whole shares, rather than fractions, was accessible to all of our associates,” said Doug McMillon, President and CEO of Walmart. “Given our growth and our plans for the future, we felt it was a good time to split the stock and encourage our associates to participate in the years to come. As Sam said, ‘We’re all in this together. That’s the secret.’”
more at: https://corporate.walmart.com/news/2024/01/30/walmart-announces-3-for-1-stock-split

Related Posts

Postal Service Delivery Holds Steady at 2.5 Days

FY23 third quarter service performance scores covering April 1 through June 9, included: *First-Class Mail: 92.3% of First-Class Mail delivered on time against the USPS service standard, an increase of 1.3 percentage points from the fiscal second quarter. *Marketing Mail: 96.0% of Marketing Mail delivered on time against the USPS service standard, an increase of 1.4 percentage points from the fiscal second quarter. *Periodicals: 88.8% of Periodicals delivered on time against the USPS service standard, an increase of 2.4 percentage points from the fiscal second quarter.

European Academy of Allergy and Clinical Immunology Extends Publishing Partnership with Wiley

The European Academy of Allergy and Clinical Immunology (EAACI) and John Wiley & Sons Inc., a global leader in research and education, have expanded their publishing partnership to include EAACI’s official open access journal Clinical and Translational Allergy (CTA) alongside their other publications, Allergy and Pediatric Allergy and Clinical Immunology, as of January 2021. CTA is a fully open access journal, edited by Prof. Jean Bousquet and Dr. Clive Grattan, and provides a dissemination of allergy research and reviews, as well as EAACI position papers, task force reports, and guidelines for an international scientific audience. “We are delighted to extend our collaboration with Wiley to include CTA in 2021. Having all three journals under the same publishing umbrella will allow them to benefit from Wiley's extensive expertise in the publishing process, while at the same time keeping up the high quality of EAACI's scientific content, including the most relevant progress and updates in the field." Tomàs Chivato, EAACI VP Science; Jean Bousquet, CTA Editor-in-Chief; Clive Grattan, CTA Editor-in-Chief.

Booksellers Outraged by Chronicle’s Rollout of John Oliver Book

Independent booksellers are expressing frustration and disappointment with Chronicle Books for its handling of comedian John Oliver’s Last Week Tonight with John Oliver Presents a Day in the Life of Marlon Bundo. Oliver announced the immediate availability of the book at the end of his Sunday, March 18 show, but to the surprise of independent booksellers, Oliver said that the book was only available at that time through Amazon. The illustrated children’s book about a gay bunny parodies the newly released Marlon Bundo’s Day in the Life of the Vice President by Vice President Mike Pence’s wife Karen and daughter Charlotte, which is told through the eyes of the family’s pet rabbit.
Back To Top
×Close search
Search